Cargando…

Effect of CpG ODN on monocytic myeloid derived suppressor cells

CpG oligonucleotides stimulate via TLR9 and enhance anti-tumor immunity, an effect attributed to the activation of NK and CD8(+) T cells. Our recent work demonstrates that CpG ODN also induce monocytic myeloid-derived suppressor cells to mature into M1 macrophages, further aiding tumor elimination....

Descripción completa

Detalles Bibliográficos
Autores principales:	Shirota, Hidekazu, Klinman, Dennis M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2012
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429593/ https://www.ncbi.nlm.nih.gov/pubmed/22934281 http://dx.doi.org/10.4161/onci.19731

Ejemplares similares

Forging a potent vaccine adjuvant: CpG ODN/cationic peptide nanorings
por: Gungor, Bilgi, et al.
Publicado: (2014)

Production of epitope-specific antibodies using peptide-CpG-ODN-liposome complex without carriers and their application as a cancer vaccine in mice
por: Lee, YoungHee, et al.
Publicado: (2012)

CpG Oligonucleotides as Cancer Vaccine Adjuvants
por: Shirota, Hidekazu, et al.
Publicado: (2015)

Plasmacytoid Dendritic Cell Response to CpG ODN Correlates with CXCL16 Expression and Is Inhibited by ox-LDL
por: Gursel, Mayda, et al.
Publicado: (2013)

DEC-205 is a cell surface receptor for CpG oligonucleotides
por: Caminschi, Irina, et al.
Publicado: (2013)

Type II natural killer T cells foster the antitumor activity of CpG-oligodeoxynucleotides
por: Zhao, Jie, et al.
Publicado: (2014)

The effect of CpG-ODN on antigen presenting cells of the foal
por: Flaminio, M Julia BF, et al.
Publicado: (2007)

Comparison of in vivo Adjuvanticity of Liposomal PO CpG ODN with Liposomal PS CpG ODN: Soluble Leishmania Antigens as a Model
por: Golali, Ensieh, et al.
Publicado: (2012)

Myeloid-derived suppressor cells, age and cancer
por: Bowdish, Dawn ME
Publicado: (2013)

Chemotherapeutic targeting of myeloid-derived suppressor cells
por: Alizadeh, Darya, et al.
Publicado: (2014)

Myeloid-derived suppressor cells link inflammation to cancer
por: Wang, Dingzhi, et al.
Publicado: (2014)

Monocytic myeloid-derived suppressor cells in advanced melanoma patients: Indirect impact on prognosis through inhibition of tumor-specific T-cell responses?
por: Martens, Alexander, et al.
Publicado: (2014)

Myeloid-derived suppressor cells and the efficacy of CD8(+) T-cell immunotherapy
por: Lesokhin, Alexander M., et al.
Publicado: (2013)

Tumor-derived lactate and myeloid-derived suppressor cells: Linking metabolism to cancer immunology
por: Husain, Zaheed, et al.
Publicado: (2013)

TRAIL is involved in CpG ODN-mediated anti-apoptotic signals
por: LIM, EUN-JUNG, et al.
Publicado: (2011)

Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment
por: Harman, María F., et al.
Publicado: (2015)

Rethinking the role of myeloid-derived suppressor cells in adoptive T-cell therapy for cancer
por: Arina, Ainhoa
Publicado: (2014)

Myeloid-derived suppressor cells as a novel target for the control of osteolytic bone disease
por: Sawant, Anandi, et al.
Publicado: (2013)

Immunological consequences of selective BRAF inhibitors in malignant melanoma: Neutralization of myeloid-derived suppressor cells
por: Schilling, Bastian, et al.
Publicado: (2013)

Limited Effect of CpG ODN in Preventing Type 1 Diabetes in NOD Mice
por: Lee, Byong Jun, et al.
Publicado: (2005)

Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial
por: Ursu, Renata, et al.
Publicado: (2015)

Orphan CpG islands as alternative promoters
por: Sarda, Shrutii, et al.
Publicado: (2017)

Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growth
por: Fujimura, Taku, et al.
Publicado: (2012)

B7x and myeloid-derived suppressor cells in the tumor microenvironment: A tale of two cities
por: Jeon, Hyungjun, et al.
Publicado: (2013)

Myeloid-derived suppressor cells in allogeneic hematopoietic stem cell transplantation: A double-edged sword?
por: Le Blanc, Katarina, et al.
Publicado: (2013)

Myeloid-derived suppressor cells as a Trojan horse: A cellular vehicle for the delivery of oncolytic viruses
por: Pan, Ping-Ying, et al.
Publicado: (2013)

Key role of the positive feedback between PGE(2) and COX2 in the biology of myeloid-derived suppressor cells
por: Obermajer, Nataŝa, et al.
Publicado: (2012)

Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells
por: Morello, Silvana, et al.
Publicado: (2014)

Toll-like receptor 9 interaction with CpG ODN – An in silico analysis approach
por: Zhou, Wei, et al.
Publicado: (2013)

Identification of Differentially Expressed lncRNAs in a CpG ODN-Activated Macrophage
por: Zheng, Ying, et al.
Publicado: (2020)

Characteristic of K3 (CpG-ODN) as a Transcutaneous Vaccine Formulation Adjuvant
por: Ito, Sayami, et al.
Publicado: (2020)

The hedgehog’s trick for escaping immunosurveillance: The molecular mechanisms driving myeloid-derived suppressor cell recruitment in hedgehog signaling-dependent tumors
por: Xie, Jingwu
Publicado: (2014)

Radiation and anti-PD-L1 antibody combinatorial therapy induces T cell-mediated depletion of myeloid-derived suppressor cells and tumor regression
por: Deng, Liufu, et al.
Publicado: (2014)

The Role of Liposomal CpG ODN on the Course of L. major Infection in BALB/C Mice
por: Hejazi, H, et al.
Publicado: (2010)

Increased Sensitivity to Chemotherapy Induced by CpG-ODN Treatment Is Mediated by microRNA Modulation
por: De Cecco, Loris, et al.
Publicado: (2013)

CpG-ODN Class C Mediated Immunostimulation in Rabbit Model of Trypanosoma evansi Infection
por: Kumar, Parveen, et al.
Publicado: (2015)

Pleiotropic action of CpG-ODN on endothelium and macrophages attenuates angiogenesis through distinct pathways
por: Wu, Jiahui, et al.
Publicado: (2016)

Radiosensitization by CpG ODN7909 in an epidermoid laryngeal carcinoma Hep-2 cell line
por: Wang, Shu, et al.
Publicado: (2017)

Treatment with phosphodiester CpG-ODN ameliorates atopic dermatitis by enhancing TGF-β signaling
por: Ham, Won-Kook, et al.
Publicado: (2021)

Factors Influencing the Differentiation of Human Monocytic Myeloid-Derived Suppressor Cells Into Inflammatory Macrophages
por: Bayik, Defne, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_08p0utiv7o9o3jp8pbucq52cu7